ML052500591
| ML052500591 | |
| Person / Time | |
|---|---|
| Site: | Palo Verde  |
| Issue date: | 08/25/2005 |
| From: | Seaman C Arizona Public Service Co |
| To: | Document Control Desk, Office of Nuclear Reactor Regulation |
| References | |
| 102-05333-CKS-TNW/CJJ | |
| Download: ML052500591 (7) | |
Text
Z jA P S A subsidiary of Pinnacle West Capital Corporation Craig K. Seaman Director Regulatory Affairs Palo Verde Nuclear Generating Station Tel. 623-393-5421 Fax 623-393-5442 CSeamaneapsc.com Mail Station 7636 P.O. Box 52034 Phoenix. Arizona 85072-2034 1 02-05333-CKS/TNW/CJJ August 25, 2005 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555-0001
Dear Sirs:
Subject:
Palo Verde Nuclear Generating Station (PVNGS)
Units 1, 2, &3 Docket Nos. STN 50-52815291530 Fitness-For-Duty Program Semiannual Performance Report Pursuant to 10 CFR 26.71 (d), Arizona Public Service Company hereby provides, as an enclosure to this letter, the Fitness-For-Duty Program Semiannual Performance Report for the reporting period of January 1, 2005 through June 30, 2005.
No commitments are being made to the NRC by this letter. Should you have any questions, please contact Thomas N. Weber at (623) 393-5764.
Sincerely, CKSITNW/CJJ/ca cc:
B. S. Mallett M. B. Fields G. G. Warnick NRC Region IV Regional Administrator NRC NRR Project Manager NRC Senior Resident Inspector for PVNGS A member of the STAPRS (Strategic Teaming and Resource Sharing) Alliance Callaway
- Comanche Peak
- Diablo Canyon
- Palo Verde
- South Texas Project
- Wolf Creek
ENCLOSURE ARIZONA PUBLIC SERVICE COMPANY FITNESS-FOR-DUTY PROGRAM SEMIANNUAL PERFORMANCE REPORT JANUARY 1, 2005 THROUGH JUNE 30, 2005
SEMIANNUAL PERFORMANCE REPORT January 1, 2005 - June 30, 2005 PREPARED BY:
William G. Thomack II
'-A
'I Signature
,7 X J, I Da) te Date APPROVED BY:
Gayle Schiavone Si na 1.
-7;/Os iDat REVIEWED BY:
Harold J. Winter Sf4natur 77 27/" -
Date
Introduction The Arizona Public Service Company (APS) Fitness-for-Duty (FFD) Program continues to remain successful in its hmission to maintain a drug-free workplace. During this reporting period, APS conducted 1844 tests. Of these, 662 were administered on a random basis. An equivalent annual testing rate of 51.6 percent was achieved during this reporting period.
APS experienced two confirmed positive random drug and alcohol tests during this reporting period. Therefore, the percentage of confirmed positive random drug and alcohol tests for this period is 0.3 percent.
Analysis of Program Results The confirmed positive drug and alcohol test results for this reporting period by type of test and type of drug are summarized in Table I and 2 respectively and are discussed below.
Pre-Access Testing:
Cocaine Marijuana Amphetamines Opiates Alcohol Total 1
4 2
1 1
9 confirmed positive tests Comments: APS tested a total of 995 individuals under the Pre-Access Testing category during this reporting period. Seven individuals tested positive. Two of the individuals tested positive for two drugs, amphetamines and marijuana. The seven individuals were contractors. Site access was denied and the individuals were released to their employers.
For Cause Testing:
Amphetamines Alcohol Cocaine Refusal to Test 1
1 1
2 Total:
5 Confirmed Positive Tests
Comments: APS tested a total of 36 individuals under the For Cause testing category during this reporting period.,For cause testing includes; behavior observation, post accident, suspected adulteration of specimnens, or an odor of alcoihol on an individual.
Five individuals tested positive. Four of the individuals testing positive were contractors. Site access was denied and the individuals were released to their employers.
One individual was an APS employee. This individual was terminated for reasons other than the positive test result.
Random Testing:
Amphetamines 1
Alcohol I
Total 2
Confirmed Positive Tests Comments: APS tested a total of 662 individuals under the random testing category during this reporting period. Two individuals tested positive. One individual was an APS employee. The individual completed a mandatory treatment program and was placed in the follow-up program. One individual was a contract employee. Site access was denied and the individual was released to the contract company.
Follow-up Testing:
Total 0
Confirmed Positive Tests Comments: APS conducted a total of 69 tests under the Follow-up category during this reporting period. None of the individuals tested were positive.
Other:
Total 0
Confirmed Positive Tests Comments: APS tested 82 individuals in the other testing category during this reporting period. This category includes pre-employment testing. There were no positive tests.
Reportable Events:
There were no reportable events during this reporting period.
Fitness for Duty Program Performance Data Personnel Subject to 10 CFR 26 June 30, 2005 Arizona Public Service Company Company Palo Verde Nuclear Generating Station (PVNGS)
Location Ouida Bland Contact Name 6 months ending (623) 393-3228 Phone(include area code)
Cutoffs: Screen/Confirmation (nglml) Appendix A to 10 CFR 26 Marijuana Cocaine Opiates 100/15 Amphetamines 300/150 Phencyclidine 300/300 Alcohol (% BAC) 1000/500 25/25 0.04%
PVNGS screening test for Marijuana uses a cut off level of 50 ng/ml Long-Term Short-Term Testing Results Licensee Contractor Contractor Employees Personnel Personnel Average Number with 2035 NA 530 Unescorted Access Categories Tested Positive Tested Positive Tested Positive Pre-Access 223 0
NA NA 772 7
For Post accident 6
0 NA NA 2
0 Cause Observed behavior 13.
I NA NA 15 4
Random.
527 1
NA NA 135 1
Follow-Up 53 0
NA NA 16 0
Other 82 0
NA NA 0
0 Total 904 2
NA NA 940 12
I I
Breakdown of Confirmed Positive Tests for Specific Substances Ampheta Phency-Refusal' Marijuana Cocaine Opiates mines cildine Alcohol to Test Total Licensee Employees 0
0.
0 0
0 2
0 2
Long-Term Contractors NA NA NA NA NA NA NA NA Short-Term Contractors 4
2 1
4 0
1 2
14 Total 4
2 1
4 0
3 2
16 Additional Information Required by 10 CFR 26.71 (d)
Specimens screening positive for marijuana at 50 ng/ml: 7 Specimens screening positive for marijuana at 100 ng/ml: 6 These numbers include blind specimens sent to offsite lab for testing.